Jadranka Bozja

age ~64

from Tucker, GA

Get Report
Also known as:
  • Jandranka Bozja
  • Jodrabca Bozja
Phone and address:
3961 Woburn Dr, Tucker, GA 30084
7704931839
Related to:
Connected to:

Jadranka Bozja Phones & Addresses

  • 3961 Woburn Dr, Tucker, GA 30084 • 7704931839
  • Atlanta, GA
  • Spokane, WA
  • Richland, WA

Work

  • Company:
    Emory university school of medicine
    2007 to 2010
  • Position:
    Sen assoc director, programs

Education

  • Degree:
    Master of Business Administration, Masters
  • School / High School:
    Emory University - Goizueta Business School
    2004 to 2006

Skills

Biotechnology • Lifesciences • Oncology • Pharmaceutical Industry • Clinical Trials • Technology Transfer • Commercialization • Strategy • Medical Devices • Drug Discovery • Clinical Development • Drug Development • Vaccines • Immunology • Infectious Diseases • Life Sciences

Industries

Biotechnology

Resumes

Jadranka Bozja Photo 1

Jadranka Bozja

view source
Location:
Atlanta, GA
Industry:
Biotechnology
Work:
Emory University School of Medicine 2007 - 2010
Sen Assoc Director, Programs
Emory University 2006 - 2007
Dir, Bd
Education:
Emory University - Goizueta Business School 2004 - 2006
Master of Business Administration, Masters Heidelberg University, Heidelberg, Germany
Skills:
Biotechnology
Lifesciences
Oncology
Pharmaceutical Industry
Clinical Trials
Technology Transfer
Commercialization
Strategy
Medical Devices
Drug Discovery
Clinical Development
Drug Development
Vaccines
Immunology
Infectious Diseases
Life Sciences
Name / Title
Company / Classification
Phones & Addresses
Jadranka Bozja
President
ZETRA BIOLOGICALS, LLC
Life Sciences R&D Vaccines Manufacturin
3961 Woburn Dr, Tucker, GA 30084

Us Patents

  • Cross-Protective Influenza Vaccine

    view source
  • US Patent:
    20120052082, Mar 1, 2012
  • Filed:
    Apr 11, 2011
  • Appl. No.:
    13/084367
  • Inventors:
    Richard W. Compans - Atlanta GA, US
    Jadranka Bozja - Tucker GA, US
    Jae-Min Song - Decatur GA, US
  • International Classification:
    A61K 39/145
    A61P 31/16
    A61P 37/04
  • US Classification:
    4241861, 4241921
  • Abstract:
    A cross-protective influenza virus vaccine has been designed based on the incorporation of the genetically engineered, highly conserved M2 influenza viral protein optionally in combination with an adjuvant such as a bacterial flagellin protein incorporated into the membrane of a virosome or virus-like particles. Immunogenicity and the breadth of cross protection efficacy are significantly enhanced using multiple copies of the influenza M2 protein as a membrane bound tetramer and/or in combination with a membrane bound adjuvant. A method for vaccinating a subject for influenza A has also been developed that results in broad and improved cross-protection against multiple subtypes of influenza A virus.
Get Report for Jadranka Bozja from Tucker, GA, age ~64
Control profile